Bcl-2, iNOS, p53 and PCNA expression in normal, disordered proliferative, hyperplastic and malignant endometrium

Area of Science:

• Gynecologic Oncology
• Molecular Pathology
• Cancer Biology

Background:

• Endometrioid adenocarcinomas (ECA) are the most common type of uterine cancer.
• Understanding the molecular mechanisms driving ECA development is crucial for targeted therapies.
• Key proteins like Bcl-2, iNOS, p53, and PCNA are implicated in cell proliferation and survival.

Purpose of the Study:

• To investigate the expression of Bcl-2, iNOS, p53, and PCNA.
• To explore the relationships between these proteins in precursor lesions and endometrioid adenocarcinomas.
• To elucidate their roles in the pathogenesis of type 1 endometrial cancer.

Main Methods:

• Immunohistochemical analysis of 91 endometrial tissue samples.
• Inclusion of benign (proliferative, secretory, disordered proliferative, atrophic endometrium, endometrial hyperplasia) and malignant tissues.
• Statistical analysis to determine protein expression levels and correlations.

Main Results:

• Elevated Bcl-2 staining observed in disordered proliferative endometrium, endometrial hyperplasia, and endometrioid cancer compared to proliferative endometrium.
• Significant differences in proliferating cell nuclear antigen (PCNA) staining between simple and complex endometrial hyperplasia.
• An inverse relationship between inducible nitric oxide synthase (iNOS) and p53 in endometrial hyperplasia, but no direct relationship in endometrioid cancer.

Conclusions:

• The interplay of iNOS, p53, and Bcl-2 differs in endometrioid adenocarcinoma development compared to other cancers.
• These proteins may play distinct roles in the progression from hyperplasia to type 1 endometrial cancer.
• Further research is warranted to fully understand the molecular pathways involved in endometrial carcinogenesis.